As of 2025-07-04, the Relative Valuation of SQZ Biotechnologies Co (SQZ) is (58.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.44 USD, the upside of SQZ Biotechnologies Co based on Relative Valuation is -13495.1%.
The range of the Relative Valuation is (47.15) - (65.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 24.2x | 20.0x |
| Forward P/E multiples | 17.5x - 28.9x | 23.2x |
| Fair Price | (47.15) - (65.26) | (58.27) |
| Upside | -10940.0% - -15102.5% | -13495.1% |
| Date | P/E |